Desoximetasone
Active ingredient · 2 therapeutic classes
Sold as TOPICORT
- Drug class
- Corticosteroids, Potent (Group Iii)
- Availability
- Prescription only
- Routes
- Topical
- Markets covered
- 2
- Products on record
- 6
- FDA reports (12 mo)
- 1,972
Overview
Plain-language summary, compiled from the cited regulatory records
Desoximetasone is a topical corticosteroid indicated for the relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses [1]. It belongs to the drug class of potent corticosteroids, specifically Group III [1]. This means it is a strong topical steroid used to treat skin conditions that cause inflammation and itching [1].
In the market, desoximetasone is available under various brand names [1]. While not a comprehensive list, examples include [1].
There were 1972 adverse event reports for desoximetasone in the past 12 months [2]. The most frequently reported events associated with desoximetasone include off-label use, systemic lupus erythematosus, glossodynia, fatigue, and Helicobacter infection [2].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| CA Canada | Health Canada | 4 | December 23, 2025 |
| US United States | FDA | 2 | May 31, 2024 |
CACanada· Health Canada
4 products
Uses
3 Pediatrics 05/2022 TABLE OF CONTENTS Sections or subsections that are not applicable at the time of authorization are not listed. RECENT MAJOR LABEL CHANGES ...................................................................................
2 TABLE OF CONTENTS ......................................................................................................... 2 PART I: HEALTH PROFESSIONAL INFORMATION.............................................................. 4 1 INDICATIONS.............................................................................................................
1 Pediatrics .......................................................................................................... 2 Geriatrics...........................................................................................................
4 2 CONTRAINDICATIONS .............................................................................................. 4 4 DOSAGE AND ADMINISTRATION ............................................................................. 1 Dosing Considerations.......................................................................................
USUnited States· FDA
2 products
Uses
INDICATIONS AND USAGE
05% are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
How to take
Drug interactions
Known interactions involving Desoximetasone. Select one for details. This list is informational and not a complete interaction checker.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]Health Canada (DPD) · 02221896 · revised December 23, 2025
- [2]FDA DailyMed · 0e72952e-8e9f-46… · revised December 9, 2023 [PDF]
- [3]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.